https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(22)00240-1/fulltext
0
0
Childhood growth hormone treatment and metabolic and cardiovascular risk in adults born small for gestational age after growth hormone cessation in the Netherlands: a 12-year follow-up study - The Lancet
+ 91 more
9/16/22 at 10:44pm
Organization
The Lancet
70 words
0
Comments
At approximately age 30 years, SGA-GH adults had a similar metabolic and cardiovascular health profile to untreated adults born SGA or appropriate for gestational age, indicating long-term metabolic and cardiovascular safety of growth hormone treatment for ch…
You are the first to view
Create an account or login to join the discussion